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Background: The conjugated linoleic acid isomer cis9trans11 CLA can be endogenously synthesized from trans
vaccenic acid (C18:1 t11) via desaturation at the delta 9 position catalyzed by the stearoyl-CoA desaturase 1 (SCD1),
also known as delta-9 desaturase (D9D). Diet, hormonal regulation of gene expression and single nucleotide
polymorphisms (SNPs) have been implicated in altering circulating levels of fatty acids. Hormonal contraceptives
(HC) have also been shown to influence levels of some fatty acids. SNPs in SCD1 have been associated with altered
levels of palmitoleic and oleic acids; however, associations between SCD1 SNPs and D9D desaturation index have
not been previously examined in relation to CLA. Herein, we investigated the effects of sex and HC use on
circulating concentrations of c9t11 CLA and D9D desaturation index. Furthermore, we determined the effects of ten
SCD1 SNPs on D9D desaturation indices estimated by product to precursor ratio of c9t11 CLA to C18:1 t11.
Methods: Plasma samples were collected from subjects (Caucasian males: n = 113; Caucasian females: n = 298;
Asian males: n = 98; Asian females: n = 277) from the Toronto Nutrigenomics and Health Study. Circulating fatty
acids levels were measured by gas chromatography.
Results: Results show that circulating c9t11 CLA concentrations are significantly higher in females than males and
they are further elevated in females using HC. In addition, a significant sex- and ethnic-specific association was
found between SCD1 SNP rs10883463 (p = 0.0014) and altered D9D activity in Caucasian males.
Conclusion: Findings from the present study identify SCD1 SNPs and hormonal contraceptives as factors altering
endogenous c9t11 CLA levels in a sex- and ethnic-specific manner.
Keywords: c9t11 CLA, SCD1, Hormonal contraceptives, Single nucleotide polymorphismsBackground
Conjugated linoleic acids (CLA) are 18 carbon polyun-
saturated fatty acids that are naturally found in ruminant
meat and milk products. CLA isomers contain
conjugated double bonds in different cis and trans con-
figurations. CLA isomers include trans10cis12 CLA,
cis11trans13 CLA and the most common isomer* Correspondence: davidma@uoguelph.ca
1Department of Human Health and Nutritional Sciences, Animal Science/
Nutrition Building, Rm 342, College of Biological Science, University of
Guelph, 491 Gordon Street, Guelph, Ontario, Canada
Full list of author information is available at the end of the article
© 2013 Abdelmagid et al.; licensee BioMed Ce
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumcis9trans11 CLA (c9t11 CLA), also known as rumenic
acid (RA) [1]. RA is the primary CLA isomer in rumin-
ant and dairy products where it constitutes more than
80% of total CLA [2-4]. Considerable attention has been
given to CLA as it has been shown to possess anti-
carcinogenic, anti-atherosclerotic and anti-inflammatory
properties [5-13].
CLA is produced through biohydrogenation of polyun-
saturated fatty acids by ruminant bacteria [14]. In
addition, the CLA isomer c9t11 can also be derived
through the delta-9-destaturation of the ruminant trans
vaccenic acid (C18:1 t11). Trans vaccenic acid is thentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and dairy products, although lesser amounts are also
produced industrially [3,15]. Ruminant TFA are sug-
gested to confer health benefits; however, more research
is needed to substantiate their beneficial effects [16]. In
a study conducted in male Hartley guinea pigs, animals
fed ruminant TFA compared to animals fed industrial
TFA had a smaller HDL particle profile; which has been
associated with a lower risk of cardiovascular and heart
disease [17]. Using a rodent model of metabolic syn-
drome, Wang et al. have shown trans vaccenic acid to
have beneficial effects on lipids and lipoproteins [18].
Furthermore, trans vaccenic acid was shown to decrease
the proinflammatory markers IL-2 and TNF-α [19,20].
In humans, trans vaccenic acid is converted to c9t11
CLA through a desaturation reaction catalyzed by
stearoyl-CoA desaturase 1 (SCD1), also known as delta-
9 desaturase (D9D) [21-25]. SCD1 is a membrane-bound
40 kDa protein localized to the endoplasmic reticulum
[23]. It introduces a cis double bond in the delta 9 pos-
ition of fatty acyl-CoA substrates, preferably palmitoyl-
CoA (C16:0) and stearoyl-CoA (C18:0) to produce
palmitoleoyl-CoA (C16:1) and oleoyl-CoA (C18:1), re-
spectively. Changes in SCD1 expression have been impli-
cated in several diseases such as skin inflammation,
pancreatic β-cell dysfunction, liver dysfunction and ath-
erosclerosis [26]. Factors contributing to changes in
SCD1 expression and SCD1 activity include hormonal
regulation and single nucleotide polymorphisms (SNPs)
[27,28]. Sex differences in SCD1 expression were dem-
onstrated in mice where females had higher levels of ex-
pression accompanied by higher levels of palmitoleic
and oleic acids in the liver [29]. However, the underlying
mechanistic basis for those differences is unknown. In
humans, sex differences in SCD1 expression or levels of
delta-9 desaturation product c9t11 CLA are not yet
determined. Hormonal contraceptives (HC) have been
shown to influence levels of the fatty acid docosahe-
xaenoic acid which have also been shown to be present
in significantly higher levels in females than in males
[30]. Effect of HC use on the delta-9 desaturation index
or c9t11 CLA levels is unknown.
SNPs in SCD1 have been associated with decreased
body mass index (BMI), waist circumference and im-
proved insulin sensitivity in elderly Swedish men [31].
Recently, SNPs in SCD1 have been shown to influence
plasma levels of 16:0, 16:1, and 18:0, as well as C-
reactive protein, in individuals of European descent [28];
however, the effect of SCD1 genetic variations on c9t11
CLA concentrations has not been previously examined.
Consequently, it is unknown whether SCD1 genetic
variants result in sex differences in circulating concen-
trations of c9t11 CLA. Therefore, the present study ex-
amined the influence of SCD1 genetic variation and HCon circulating concentrations of c9t11 CLA in men and
women in Canadian population of Caucasians and Asians.
Methods
Study population
Participants (Caucasians: males = 113, females = 298;
Asians: males = 98, females = 277) were recruited as part
of the Toronto Nutrigenomics and Health (TNH) Study
[32] between September 2004 and July 2009. Ages of
participants ranged between 20 and 29 years old and
written informed consent was obtained from all of those
who participated. Anthropometric measurements were
recorded for all participants and health, life style, and
food frequency questionnaires were completed by sub-
jects. Total energy intake from fat and physical activity
scores were calculated from completed questionnaires as
previously described [32,33]. Following a 12 h fast,
plasma samples were collected for measurement of bio-
markers of glucose and lipid metabolism. HOMA-IR was
calculated using the homeostasis model assessment
method [34]. Women who were pregnant or breastfeeding
were not included in the study. No other exclusion criteria
were included in these analyses. The study protocol was
approved by the Research Ethics Boards at the University
of Toronto and University of Guelph.
Gas chromatography analysis
Subjects were required to fast overnight for a minimum
of 12 h prior to blood collection and separation of
plasma. Samples were frozen and stored at - 80°C. Fro-
zen plasma samples were thawed on ice for 30 min and
a mixture of chloroform: methanol (2:1 v/v) was added
to a 50 μl aliquot as described previously [35]. Free fatty
acid C17:0 was used as an internal standard (5 μg of
1 mg/ml stock). Samples were flushed with nitrogen gas
prior to storage over night at 4°C. The next day, samples
were subjected to a double extraction, saponification,
methylation and quantification of fatty acid methyl es-
ters, as previously described [36]. Fatty acid methyl es-
ters were separated by gas chromatography using an
Agilent7890A gas chromatograph (Agilent Technologies,
Palto, Alto, Ca) with a Supelco SP 2560 fused-silics
capillary column (100 m × 0.25 mm i.d., 0.2 μm film
thickness; Sigma-Aldrich, St-Louis, MO). The carrier
gas, Hydrogen, was set at a constant flow rate of 30 mL/
min. Samples were injected in splitless mode. Both in-
jector and detector ports were set at 250°C. Fatty acid
methyl esters were eluted through the column using
temperature program of: 0.2 min at 60°C, then increas-
ing 13°C/min until a temperature of 170°C was reached.
After 4 min at 170°C, the temperature: increased 6.5°C/
min to 175°C, increased 2.6°C/min to 185°C, increased
1.3°C/min to 190°C, and finally increased 13°C/min to
240°C and held at 240°C for 13 min. The processing
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a known internal standard (Nu-Chek-Prep, Elysian, MN)
were used to identify fatty acids. Fatty acid peak areas
were determined using EZChrom Elite software (Version
3.3.2) [37]. The internal standard was used to calculate
fatty acid concentrations (μg/ml). An estimate of delta-
9-desaturase (D9D) desaturation index was calculated by
dividing concentrations of product (18:2c9t11 CLA) by
precursor (18:1 t11) as previously described [36].Genotyping
Identification of SCD1 SNPs, selection of SNPs, and
genotyping was performed as previously described by
Stryjecki et al. [28].Statistical analysis of data
Results are expressed as mean ± standard error mean.
All data was analyzed using JMP genomics software V5
(SAS Institute, Cary, NC), which was also used to test
Hardy-Weinberg equilibrium for each genotype. A stu-
dent’s t-test was used to determine differences in fatty
acid concentrations and ratios between males and fe-
males. A Tukey’s HSD post-hoc test was used to deter-
mine differences in desaturase indices for each genotype.
P-values of analyses of fatty acid levels or desaturase in-
dices were determined using linear regression models
which were adjusted for BMI, age, total energy intake
from dietary fat and physical activity. Linear regression
models were used to identify associations between indi-
vidual SNPs, desaturase indices and use of hormonal
contraceptives and were adjusted for BMI, age, % of
Total Energy from Dietary Fat and physical activity. A
p-value of < 0.05 was considered statistically significant.Table 1 General characteristics of study population at fasting
Caucasians
Males Females
Population (#) 113 298
Hormonal contraceptive users (%) N/A 46.0
Age (yrs) 23.1 ± 0.2 23.1 ± 0.1
BMI (kg/m2) 23.3 ± 0.3 23.1 ± 0.2
HOMA-IR 1.16 ± 0.08 1.39 ± 0.05
Glucose (mmol/L) 4.88 ± 0.07 4.70 ± 0.02
Insulin (pmol/L) 37.1 ± 2.1 47.4 ± 1.7
Total cholesterol (mmol/L) 3.97 ± 0.07 4.35 ± 0.05
HDL-cholesterol (mmol/L) 1.38 ± 0.03 1.69 ± 0.02
LDL-cholesterol (mmol/L) 2.16 ± 0.06 2.23 ± 0.04
Triglycerides (mmol/L) 0.96 ± 0.05 0.97 ± 0.02
Free fatty acids (mmol/L) 454 ± 24.6 489 ± 14.2
% of Total Energy from Dietary Fat 27.4 ± 0.6 27.9 ± 0.4
Statistical differences were determined using a Student’s T-test. The * denotes p-vaResults
Study population
General characteristics of subjects used in the study are
presented in Table 1.Gender influences plasma concentrations of 18:2c9t11
and D9D index
Plasma concentrations of fatty acids are presented in
Table 2. There was no significant difference in 18:1 t11
concentrations between Caucasian males and females;
however, Asian females had significantly higher concen-
trations of 18:1 t11 compared to Asian males (p = 0.04).
Both Caucasian and Asian females had significantly
higher concentrations of 18:2c9t11 and D9D indices
compared to males within the same ethnicity (p < 0.01).Association of hormonal contraceptive (HC) use and
altered fatty acid concentrations
Plasma concentrations of fatty acids in females using
hormonal contraceptives (HC) compared to females not
using contraceptives are presented in Table 3. In
Caucasians, females using HC had significantly higher
concentrations of 18:1 t11 and 18:2c9t11 than Caucasian
females who were not users (p = 0.0037, p < 0.0001, re-
spectively). In Asians, there was no significant difference
in 18:1 t11 concentrations between users and non-users;
however, females using HC had significantly higher con-
centrations of 18:2c9t11 (p < 0.0001). In both Caucasians
and Asians, [18:2c9t11/18:1 t11] desaturase indices
tended to be higher in females using HC (p = 0.0581 and
p = 0.0503, respectively) than in females not using con-
traceptives (Table 3).state compared by sex and separated by ethnicity
Asians
P-value Males Females P-value
98 277
N/A 15.5
0.87 22.4 ± 0.2 22.1 ± 0.1 0.26
0.54 23.2 ± 0.3 21.2 ± 0.1 <0.01*
0.02* 1.42 ± 0.08 1.45 ± 0.10 0.84
<0.01* 4.95 ± 0.04 4.73 ± 0.02 <0.01*
<0.01* 45.7 ± 2.3 48.1 ± 2.9 0.62
<0.01* 4.13 ± 0.08 4.29 ± 0.04 <0.05*
<0.01* 1.39 ± 0.03 1.68 ± 0.02 <0.01*
0.32 2.29 ± 0.07 2.21 ± 0.04 0.24
0.86 0.98 ± 0.05 0.91 ± 0.02 0.19
0.21 453 ± 21.4 521 ± 15.4 0.02*
0.56 26.3 ± 0.5 26.2 ± 0.3 0.98
lues which are significant (< 0.05).
Table 2 Estimates of fatty acid concentrations (μg/ml) in Caucasian and Asian males and females
Fatty acids Caucasians Asians
Males Females P-value Males Females P-value
18:0 131.9 ± 3.3 137.7 ± 1.8 0.08 133.1 ± 3.0 140.1 ± 1.8 0.03*
18:1 t9 4.1 ± 0.2 4.7 ± 0.2 0.04* 3.7 ± 0.2 4.4 ± 0.2 <0.01*
18:1 t11 4.6 ± 0.2 4.8 ± 0.2 0.50 4.0 ± 0.2 4.3 ± 0.2 0.04*
18:2c9t11 4.5 ± 0.2 5.3 ± 0.1 <0.01* 3.7 ± 0.1 4.1 ± 0.1 <0.01*
18:2c11t13 0.5 ± 0.0 0.6 ± 0.0 0.15 0.5 ± 0.1 0.5 ± 0.0 <0.01*
18:2t10c12 1.1 ± 0.1 1.2 ± 0.0 0.16 1.2 ± 0.1 1.2 ± 0.0 0.73
18:2c9t11/18:1 t11 1.0 ± 0.0 1.2 ± 0.0 <0.01* 1.1 ± 0.0 1.1 ± 0.0 0.01*
Select fatty acids used as substrate and product of D9D, desaturase index and major CLA isomers are reported. The * denotes p-values which are significant
(< 0.05). P-values were determined using linear regression models which were adjusted for BMI, age, % of Total Energy from Dietary Fat and physical activity.
Caucasian Males: n = 113; Caucasian females: n = 298; Asian Males: n = 98; Asian Females: n = 277.
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The 10 selected SNPs from the SCD1 gene were in
HWE in Caucasian males and females as well as in the
Asian females (Table 4). SCD1 SNP: rs575338 was not
polymorphic (MAF = 0) in Asian males and, therefore,
was excluded from further analyses in this subgroup of
subjects (Table 4).
Association of SCD1 SNPs and [18:2c9t11/18:1 t11]
desaturase indices
Regression analysis of ten SCD1 SNPS and D9D indices
[18:2c9t11/18:1 t11] revealed no significant associations
in Caucasian females, Asian males, or Asian females
(Tables 5 and 6). However, in Caucasian males
rs10883463 was significantly associated with altered
D9D desaturation index (p < 0.01). In this population,
carriers of the minor C allele (19 out of 113 Caucasian
males) had significantly lower D9D desaturase indices
compared to homozygote carriers of the common T
allele (Table 5). Further analysis to determine associa-
tions between rs10883463 and other D9D desaturation
indices ([18:1/18] and [16:1/16]) revealed no significant
associations (data not shown). Thus, the association
identified between rs10883463 and [18:2c9t11/18:1 t11]Table 3 Estimates of fatty acid concentrations (μg/ml) in Cauc
Fatty acids Caucasians
non (n = 161) HC (n = 137)
18:0 134.7 ± 2.5 141.3 ± 2.5
18:1 t9 4.2 ± 0.2 5.2 ± 0.3
18:1 t11 4.4 ± 0.2 5.3 ± 0.3
18:2c9t11 4.5 ± 0.1 6.1 ± 0.2
18:2c11t13 0.6 ± 0.0 0.6 ± 0.0
18:2t10c12 1.1 ± 0.1 1.2 ± 0.0
18:2c9t11/18:1 t11 1.2 ± 0.1 1.3 ± 0.0
Select fatty acids used as substrate and product of D9D, desaturase index and majo
P-values were determined using linear regression models which were adjusted for B
Abbreviations: HC, females using hormonal contraceptives; non, females that are nodesaturase index potentially reveals a substrate specific
association between this SNP and D9D enzymatic activ-
ity; however, this association was lost when we adjusted
for multiple testing.
Discussion
Circulating levels of c9t11 CLA may be potentially
influenced by a number of factors including differences
in dietary intake [38,39], differential expression of SCD1,
or genetic variations in SCD1 leading to differential en-
zymatic activity. The latter two factors have not been
previously examined and are the focus of the present
study where we show sex-specific modulation of circu-
lating CLA.
Firstly, plasma concentrations of c9t11 CLA in two
major ethnicities and both sexes were quantified on an
absolute basis. These results revealed significant differ-
ences in circulating plasma concentrations of c9t11 CLA
between males and females in both ethnicities. Females
had significantly higher circulating c9t11 concentrations
than their male counterparts (p < 0.01). Previously,
Zlatanos et al. reported plasma CLA levels in humans
but as percent of total fatty acids and although both
males and females were included in the study,asian and Asian females using hormonal contraceptives
Asians
P-value non (n = 234) HC (n = 43) P-value
0.03 139.4 ± 2.0 143.6 ± 4.2 0.20
<0.01* 4.2 ± 0.2 5.5 ± 0.5 0.02*
<0.01* 4.2 ± 0.2 5.0 ± 0.4 0.13
<0.01* 3.9 ± 0.1 5.2 ± 0.3 <0.01*
0.07 0.5 ± 0.0 0.7 ± 0.1 <0.01*
0.12 1.2 ± 0.0 1.3 ± 0.1 0.26
0.06 1.1 ± 0.0 1.2 ± 0.1 0.05
r CLA isomers are reported. *denotes p-values which are significant (< 0.05).
MI, age, % of Total Energy from Dietary Fat and physical activity.
t using hormonal contraceptives.
Table 4 HWE values of SCD1 and their genotype frequencies
SNP Caucasians Asians
Males Females Males Females
HWE Major allele MAF HWE Major allele MAF HWE Major allele MAF HWE Major allele MAF
rs10883463 0.79 T 0.09 0.99 T 0.10 0.99 T 0.01 0.98 T 1.9•10-3
rs417669878 0.79 G 0.42 0.99 G 0.42 0.98 G 0.26 0.98 G 0.28
rs2060792 0.83 A 0.26 0.99 A 0.29 0.99 A 0.39 0.98 A 0.31
rs3071 0.79 T 0.29 0.99 T 0.31 0.98 T 0.27 0.98 T 0.28
rs3793766 0.79 C 0.12 0.99 C 0.08 0.99 C 0.17 0.98 C 0.18
rs3793767 0.82 T 0.40 0.99 T 0.37 0.98 T 0.45 0.98 T 0.35
rs490726 0.67 T 0.22 0.99 T 0.19 0.99 T 0.23 0.98 T 0.28
rs522951 0.83 G 0.48 0.99 G 0.49 0.99 G 0.42 0.98 G 0.32
rs569184 0.79 C 0.12 0.99 C 0.08 0.99 C 0.20 0.98 C 0.28
rs575338 0.79 G 0.15 0.99 G 0.13 NP G 0.98 G 5.6•10-3
SNPs with HWE p-values less than 0.05 are not in Hardy-Weinberg Equilibrium. Caucasian Males: n = 113; Caucasian females: n = 298; Asian Males: n = 98; Asian
Females: n = 277. Abbreviations: HWE, Hardy-Weinberg Equilibrium p-values; MAF, minor allele frequency; NP, not polymorphic (MAF = 0).
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performed [39]. In the present study plasma concentra-
tions of fatty acids were determined because they pro-
vide a quantitative perspective on the pool size as
compared to relative percent composition, which is
influenced by the abundance of other fatty acids. Others
have determined plasma concentrations of CLA in diet-
ary intervention studies [38,40,41] which fall within the
same range found in this study (0.5 - 40 μmol/L). Herbel
et al. included both males and females in their study of
the effects of sunflower consumption on circulating
CLA concentrations [40]; however, comparison of circu-
lating c9t11 CLA concentrations between males and
females or different ethnicities was not performed. We
recognize that differences in CLA concentrations, deter-
mined in this study, between males and females may beTable 5 Estimates of D9D activity according to genotype for e
[18:2c9t11/18:1 t11] in males
MM Mm mm P-v
rs10883463 1.077 ± 0.036a 0.769 ± 0.048b - <0.
rs17669878 1.079 ± 0.070 0.977 ± 0.040 1.064 ± 0.076 0.2
rs2060792 1.015 ± 0.037 0.998 ± 0.061 1.215 ± 0.179 0.6
rs3071 1.037 ± 0.052 1.024 ± 0.046 0.913 ± 0.051 0.7
rs3793766 1.003 ± 0.036 1.083 ± 0.078 1.200 0.5
rs3793767 0.939 ± 0.042 1.043 ± 0.051 1.111 ± 0.097 0.2
rs490726 1.073 ± 0.042 0.960 ± 0.053 0.856 ± 0.344 0.2
rs522951 1.044 ± 0.046 1.011 ± 0.050 1.019 ± 0.081 0.7
rs569184 1.010 ± 0.036 1.060 ± 0.079 1.200 0.7
rs575338 1.024 ± 0.042 1.024 ± 0.045 1.003 ± 0.155 0.9
Results of analysis of 10 SNPs from SCD1 for associations with D9D activity index [1
different between groups. P-values were determined using linear regression model
physical activity. Caucasian Males: n = 113; Caucasian females: n = 298; Asian Males:
m, minor; ‘-’ indicates that no subjects with this genotype were present in this populatviewed as small. Whether these apparent small changes
are relevant to health will require further human studies.
Nonetheless, these data contribute to our fundamental
knowledge of baseline levels of CLA, and factors influ-
encing these levels, which will be necessary for such
studies. Our study participants were not consuming a
standardized diet; however, values for energy intake from
fat (i.e. % of Total Energy from Dietary Fat) were calcu-
lated with food frequency questionnaires and included
as a covariate in our linear regression models in order to
account for potential differences in fat intake. It is plaus-
ible that diet contributes to circulating c9t11 CLA con-
centrations in a sex-specific manner; however, according
to a recent study by Nikpartow et al., Canadian females
have lower milk consumption than Canadian males [42].
And in an overview of Canadian eating habits, malesach SCD1 SNP in Caucasians
[18:2c9t11/18:1 t11] in females
alue MM Mm mm P-value
01* 1.206 ± 0.036 1.244 ± 0.061 1.505 ± 0.170 0.75
3 1.248 ± 0.041 1.195 ± 0.050 1.207 ± 0.074 0.72
2 1.251 ± 0.053 1.175 ± 0.036 1.229 ± 0.088 0.58
8 1.202 ± 0.031 1.224 ± 0.059 1.238 ± 0.105 0.87
9 1.217 ± 0.035 1.209 ± 0.057 1.084 ± 0.391 0.94
5 1.178 ± 0.043 1.252 ± 0.052 1.200 ± 0.054 0.81
3 1.215 ± 0.041 1.217 ± 0.046 1.229 ± 0.107 0.99
8 1.125 ± 0.055 1.252 ± 0.049 1.237 ± 0.048 0.42
2 1.223 ± 0.035 1.198 ± 0.054 0.637 ± 0.055 0.38
9 1.193 ± 0.029 1.291 ± 0.098 1.188 ± 0.084 0.44
82c9t11:181 t11]. Different letters (a or b) denote values that are significantly
s which were adjusted for BMI, age, % of Total Energy from Dietary Fat and
n = 98; Asian Females: n = 277. Abbreviations: D9D, delat-9-desaturase; M, major;
ion.
Table 6 Estimates of D9D activity according to genotype for each SCD1 SNP in Asians
[18:2c9t11/18:1 t11] in males [18:2c9t11/18:1 t11] in females
MM Mm mm P-value MM Mm mm P-value
rs10883463 1.039 ± 0.041 0.813 ± 0.064 - 0.46 1.085 ± 0.027 0.783 - 0.23
rs17669878 1.094 ± 0.059 0.966 ± 0.052 0.910 ± 0.118 0.18 1.035 ± 0.035 1.139 ± 0.043 1.061 ± 0.096 0.28
rs2060792 0.949 ± 0.049 1.052 ± 0.064 1.185 ± 0.107 0.27 1.090 ± 0.040 1.058 ± 0.038 1.185 ± 0.084 0.37
rs3071 1.069 ± 0.061 0.959 ± 0.048 1.103 ± 0.121 0.34 1.052 ± 0.038 1.143 ± 0.041 0.939 ± 0.063 0.11
rs3793766 1.035 ± 0.047 1.053 ± 0.081 0.752 ± 0.036 0.88 1.072 ± 0.030 1.117 ± 0.056 0.906 ± 0.081 0.59
rs3793767 0.993 ± 0.057 1.028 ± 0.058 1.120 ± 0.104 0.66 1.109 ± 0.044 1.051 ± 0.037 1.120 ± 0.067 0.54
rs490726 1.035 ± 0.048 1.070 ± 0.077 0.795 ± 0.051 0.68 1.056 ± 0.034 1.128 ± 0.044 1.038 ± 0.101 0.19
rs522951 0.975 ± 0.053 1.030 ± 0.062 1.164 ± 0.102 0.40 1.095 ± 0.041 1.058 ± 0.038 1.156 ± 0.080 0.42
rs569184 1.041 ± 0.049 1.052 ± 0.076 0.807 ± 0.064 0.86 1.045 ± 0.034 1.129 ± 0.046 1.070 ± 0.093 0.25
rs575338 N/A 1.082 ± 0.027 0.815 ± 0.143 - 0.47
Results of analysis of 10 SNPs from SCD1 for associations with D9D activity index [182c9t11:181 t11]. P-values were determined using linear regression models
which were adjusted for BMI, age, % of Total Energy from Dietary Fat and physical activity. Caucasian Males: n = 113; Caucasian females: n = 298; Asian Males:
n = 98; Asian Females: n = 277. Abbreviations: D9D, delat-9-desaturase; M, major; m, minor; na, not applicable; ‘-’ indicates that no subjects with this genotype were
present in this population.
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Thus, the significantly higher levels of CLA in females
compared to males observed in this study has a low likeli-
hood to be a result of differences in dietary intake of CLA.
In addition to diet, differential gene expression of
SCD1 can contribute to the differences observed in
c9t11 CLA concentrations between males and females.
Several hormones have been shown to affect SCD1 ex-
pression [44]; thus, they could also contribute to sex dif-
ferences. In that regard, further stratification of female
population by HC use revealed that female users of HC
had significantly higher circulating c9t11 CLA concen-
trations than females who were non-users in both
Caucasian and Asian populations. Recently, an examin-
ation of the effect of HC use on proteomic biomarkers
in plasma of TNH study participants revealed that while
use of HC had a significant effect on alteration of prote-
omic biomarkers, the type of HC used and duration of
use had no apparent effect. Thus, further stratification of
our analysis according to type of HC used or duration of
use was not performed in this study [45]. Plasma con-
centrations of c9t11CLA and 18:1 t11 were used to esti-
mate D9D desaturation index. Although there was a
trend towards greater [18:2c9t11/18:1 t11] desaturase in-
dices in females using HC from both ethnicities, use of
HC was not significantly associated with altered D9D
desaturase index (Table 3). Several hormones have been
shown to modulate SCD1 expression. For instance, insu-
lin has been shown to have a positive effect on SCD1
transcription, while leptin and estrogen were shown to
act as inhibitors [44]. Although estrogen is an inhibitor
of SCD1 expression, the effect of estrogen or hormonal
contraceptives on circulating c9t11 CLA concentrations
have not been previously reported. HC have been shown
to increase levels of the polyunsaturated fatty aciddocosahexaenoic acid in females using contraceptives
compared to females that were not [30]. The positive as-
sociation between HC and c9t11 CLA levels observed in
this study warrants further research to elucidate the
mechanism by which HC can increase circulating levels
of c9t11 CLA. Future research by our laboratory will
also investigate the effect of HC use on other D9D prod-
ucts such as 18:1n9 and 16:1n7.
To the best of our knowledge, association between
SCD1 SNPs and D9D activity, estimated by [18:2c9t11/
18:1 t11] desaturase index, has not been previously
reported. To determine whether SCD1 SNPs contributed
to the different levels of c9t11 CLA or to differences in
D9D deasturase index between sexes, linear regression
analyses were performed. Results revealed that rs1088-
3463 was significantly (p = 0.0014) associated with
altered D9D desaturation index in Caucasian males
(Table 5). Of the Caucasian male participants in our
study cohort, 17% had the genotype associated with
decreased D9D desaturation index; however, linear
regression models revealed no significant association
between D9D indices and SCD1 SNPs in the 3 additional
populations tested (Caucasian females, Asian males and
Asian females). The lack of additional associations be-
tween rs10883463 and other D9D indices (16:1/16:0 and
18:1/18:0) within the Caucasian male population led us
to conclude that the association identified between this
SNP and CLA may suggest a degree of specificity for
18:1 t11; however, this requires confirmation in other
populations in order to substantiate this hypothesis. Fur-
thermore, we acknowledge that this association was not
significant following an adjustment for multiple testing,
further reinforcing the need for independent verification.
Nevertheless, in a recent study of variations of SCD1
and associations with relative levels of palmitic and
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et al. identified a significant association between SCD1
SNP rs2060792 and lower palmitic acid but higher ste-
aric acid levels in Caucasian women only; however, asso-
ciations with [16:1/16:0] and [18:1/18:0] desaturase
indices were not significant [28]. Our work in the
present study, which has used a much larger cohort,
supports this lack of association. The D9D activity is
highest for 18:1/18:0, intermediate for c9t11/t11 and
lowest for 16:1/16:0. While there is emerging evidence
that SCD1 polymorphisms are associated with either the
precursor, product or desaturase indices of relevant fatty
acids, there remains a need for direct evidence to
establish these potential cause-effect relationships. Fur-
ther validation is required to demonstrate the direct
relationship between the SNP identified in this study
(rs10883463) and SCD1 biochemistry.
In this study we acknowledge the limitation of
using plasma as a source for fatty acid measurements,
which typically reflects a combination of recent diet-
ary intake and hepatic synthesis; however, since sub-
jects fasted overnight prior to blood collection the
contribution of dietary fat to the blood fatty acid pro-
file is expected to be negligible. Although red blood
cells or adipose tissue might be argued to better re-
flect long term status, Baylin et al. found that fasting
plasma fatty acids correlated with fatty acids in adi-
pose tissue [46]. However, there remains a need for
more extensive studies to determine whether plasma,
red blood cells, adipose tissue or other tissues are
most suited for correlation analysis with SCD1 poly-
morphisms. Another limitation to the present study
was that food frequency questionnaire data for CLA
did not correlate with plasma CLA values (data not
shown), suggesting that the FFQ used in the present
study may lack sensitivity with regards to estimating
dietary CLA intake. Therefore we cannot fully negate
the contribution of diet to plasma fatty acid levels.
Future studies require careful measurement of CLA
from multiple blood fractions in tandem with more
extensive and detailed recording of dietary CLA in-
take. Nonetheless, results from this study provide
fundamental knowledge regarding determinants of cir-
culating CLA levels. Data demonstrate a minor role
for genetic variation in SCD1 in determining circulat-
ing CLA levels in different ethnicities or sexes and a
significant role for hormonal contraceptive use in
altering circulating CLA levels in females. These find-
ings can be utilized in future clinical and nutritional
studies when it is essential to understand factors that
may have a significant influence on baseline levels of
CLA (i.e. hormonal contraceptive use) versus factors
that may have only a minor influence on CLA vari-
ation (i.e. genetic polymorphisms in SCD1).Conclusion
Overall, this study demonstrates that sex, HC use and
SCD1 polymorphisms can influence c9t11 CLA concen-
trations. The implications of CLA in chronic diseases such
as obesity, inflammation, cardiovascular disease and can-
cer [47] necessitate better understanding of the diverse
factors influencing circulating concentrations of this fatty
acid as well as their sex- and ethnic-specific effects.
Abbreviations
BMI: Body mass index; CLA: Conjugated linoleic acid; D9D: Delta-9
desaturase; HC: Hormonal contraceptives; HWE: Hardy-Weinberg equilibrium;
MAF: Minor allele frequency; RA: Rumenic acid; SCD1: Stearoyl-CoA
desaturase 1; SNP: Single nucleotide polymorphism; TFA: Trans fatty acid.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
SA performed data analysis, interpreted results, assisted with gas
chromatography and drafted the manuscript. SC carried out gas
chromatography analyses and critically revised manuscript. JW assisted in
data analysis. KR carried out genotyping studies. DN collected DNA samples
from all participants. AB, AE and DMM assisted in interpretation of results
and critically revised manuscript. DWLM conceived and designed study,
assisted in interpretation of data and critically revised manuscript. All authors
read and approved the final manuscript.
Acknowledgements
This research was funded by grants from the Advanced Food and Materials
Network (DMM and AE-S), the Public Health Agency of Canada (DMM and
AB), and the Canada Foundation for Innovation with matching funds from
the Ontario Research Fund (DWLM and DMM) and Natural Sciences and
Engineering Research Council of Canada (DWLM). The authors would like to
thank Lyn Hillyer for technical support.
Author details
1Department of Human Health and Nutritional Sciences, Animal Science/
Nutrition Building, Rm 342, College of Biological Science, University of
Guelph, 491 Gordon Street, Guelph, Ontario, Canada. 2Department of
Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada. 3Office
for Biotechnology, Genomics and Population Health, Public Health Agency of
Canada, Toronto, Ontario, Canada.
Received: 26 February 2013 Accepted: 16 July 2013
Published: 18 July 2013
References
1. Kepler CR, Hirons KP, McNeill JJ, Tove SB: Intermediates and products of
the biohydrogenation of linoleic acid by Butyrinvibrio fibrisolvens. J Biol
Chem 1966, 241:1350–1354.
2. Kraft J, Hanske L, Mockel P, Zimmermann S, Hartl A, Kramer JK, et al: The
conversion efficiency of trans-11 and trans-12 18:1 by Delta9-desatura-
tion differs in rats. J Nutr 2006, 136:1209–1214.
3. Mendis S, Cruz-Hernandez C, Ratnayake WM: Fatty acid profile of Canadian
dairy products with special attention to the trans-octadecenoic acid and
conjugated linoleic acid isomers. J AOAC Int 2008, 91:811–819.
4. Ma DW, Wierzbicki AA, Field CJ, Clandinin MT: Conjugated linoleic acid in
canadian dairy and beef products. J Agric Food Chem 1999, 47:1956–1960.
5. Pariza MW, Hargraves WA: A beef-derived mutagenesis modulator inhibits
initiation of mouse epidermal tumors by 7,12-dimethylbenz[a]anthracene.
Carcinogenesis 1985, 6:591–593.
6. Belury MA: Inhibition of carcinogenesis by conjugated linoleic acid:
potential mechanisms of action. J Nutr 2002, 132:2995–2998.
7. McLeod RS, LeBlanc AM, Langille MA, Mitchell PL, Currie DL: Conjugated
linoleic acids, atherosclerosis, and hepatic very-low-density lipoprotein
metabolism. Am J Clin Nutr 2004, 79:1169S–1174S.
Abdelmagid et al. Nutrition & Metabolism 2013, 10:50 Page 8 of 8
http://www.nutritionandmetabolism.com/content/10/1/508. Kritchevsky D, Tepper SA, Wright S, Czarnecki SK, Wilson TA, Nicolosi RJ:
Conjugated linoleic acid isomer effects in atherosclerosis: growth and
regression of lesions. Lipids 2004, 39:611–616.
9. Lock AL, Parodi PW, Bauman DE: The biology of trans fatty acids:
implications for human health and the dairy industry. Australian Journal
of Dairy Technology 2005, 60:134–142.
10. O’Shea M, Bassaganya-Riera J, Mohede IC: Immunomodulatory properties
of conjugated linoleic acid. Am J Clin Nutr 2004, 79:1199S–1206S.
11. Reynolds CM, Loscher CE, Moloney AP, Roche HM: Cis-9, trans-11
-conjugated linoleic acid but not its precursor trans-vaccenic acid
attenuate inflammatory markers in the human colonic epithelial cell line
Caco-2. Br J Nutr 2008, 100:13–17.
12. Huot PS, Sarkar B, Ma DW: Conjugated linoleic acid alters caveolae
phospholipid fatty acid composition and decreases caveolin-1
expression in MCF-7 breast cancer cells. Nutr Res 2010, 30:179–185.
13. Ma DW, Field CJ, Clandinin MT: An enriched mixture of trans-10, cis-12
-CLA inhibits linoleic acid metabolism and PGE2 synthesis in MDA-MB
-231 cells. Nutr Cancer 2002, 44:203–212.
14. Stender S, Astrup A, Dyerberg J: Ruminant and industrially produced trans
fatty acids: health aspects. Food Nutr Res 2008, :52.
15. Allison DB, Egan SK, Barraj LM, Caughman C, Infante M, Heimbach JT:
Estimated intakes of trans fatty and other fatty acids in the US
population. J Am Diet Assoc 1999, 99:166–174.
16. Gebauer SK, Psota TL, Kris-Etherton PM: The diversity of health effects of
individual trans fatty acid isomers. Lipids 2007, 42:787–799.
17. Rice BH, Kraft J, Destaillats F, Bauman DE, Lock AL: Ruminant-produced
trans-fatty acids raise plasma total and small HDL particle concentrations
in male Hartley guinea pigs. J Nutr 2010, 140:2173–2179.
18. Wang Y, Lu J, Ruth MR, Goruk SD, Reaney MJ, Glimm DR, et al: Trans-11
vaccenic acid dietary supplementation induces hypolipidemic effects in
JCR:LA-cp rats. J Nutr 2008, 138:2117–2122.
19. Blewett HJ, Gerdung CA, Ruth MR, Proctor SD, Field CJ: Vaccenic acid
favourably alters immune function in obese JCR:LA-cp rats. Br J Nutr
2009, 102:526–536.
20. Gebauer SK, Chardigny JM, Jakobsen MU, Lamarche B, Lock AL, Proctor SD,
et al: Effects of ruminant trans fatty acids on cardiovascular disease and
cancer: a comprehensive review of epidemiological, clinical, and
mechanistic studies. Adv Nutr 2011, 2:332–354.
21. Corl BA, Barbano DM, Bauman DE, Ip C: cis-9, trans-11 CLA derived
endogenously from trans-11 18:1 reduces cancer risk in rats. J Nutr 2003,
133:2893–2900.
22. Kay JK, Mackle TR, Auldist MJ, Thomson NA, Bauman DE: Endogenous
synthesis of cis-9, trans-11 conjugated linoleic acid in dairy cows fed
fresh pasture. J Dairy Sci 2004, 87:369–378.
23. Strittmatter P, Spatz L, Corcoran D, Rogers MJ, Setlow B, Redline R:
Purification and properties of rat liver microsomal stearyl coenzyme A
desaturase. Proc Natl Acad Sci USA 1974, 71:4565–4569.
24. Enoch HG, Catala A, Strittmatter P: Mechanism of rat liver microsomal stearyl-
CoA desaturase. Studies of the substrate specificity, enzyme-substrate
interactions, and the function of lipid. J Biol Chem 1976, 251:5095–5103.
25. Flowers MT, Ntambi JM: Role of stearoyl-coenzyme A desaturase in
regulating lipid metabolism. Curr Opin Lipidol 2008, 19:248–256.
26. Liu X, Strable MS, Ntambi JM: Stearoyl CoA desaturase 1: role in cellular
inflammation and stress. Adv Nutr 2011, 2:15–22.
27. Mercuri O, Peluffo RO, Brenner RR: Effect of insulin on the oxidative
desaturation ofa-linolenic, oleic and palmitic acids. Lipids 1967, 2:284–285.
28. Stryjecki C, Roke K, Clarke S, Nielsen D, Badawi A, El-Sohemy A, et al:
Enzymatic activity and genetic variation in SCD1 modulate the
relationship between fatty acids and inflammation. Mol Genet Metab
2012, 105:421–427.
29. Lee KN, Pariza MW, Ntambi JM: Differential expression of hepatic stearoyl-
CoA desaturase gene 1 in male and female mice. Biochim Biophys Acta
1996, 1304:85–88.
30. Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL: Docosahexaenoic
acid concentrations are higher in women than in men because of
estrogenic effects. Am J Clin Nutr 2004, 80:1167–1174.
31. Warensjo E, Ingelsson E, Lundmark P, Lannfelt L, Syvanen AC, Vessby B, et al:
Polymorphisms in the SCD1 gene: associations with body fat distribution
and insulin sensitivity. Obesity (Silver Spring) 2007, 15:1732–1740.
32. Fontaine-Bisson B, Wolever TM, Connelly PW, Corey PN, El-Sohemy A:
NF-kappaB -94Ins/Del ATTG polymorphism modifies the associationbetween dietary polyunsaturated fatty acids and HDL-cholesterol in two
distinct populations. Atherosclerosis 2009, 204:465–470.
33. Lee IM, Paffenbarger RS Jr: Physical activity and stroke incidence: the
Harvard Alumni Health Study. Stroke 1998, 29:2049–2054.
34. Matthews DR, Connolly AA, Holman RR, Turner RC: Physiology of insulin
secretion: problems of quantity and timing. Neth J Med 1985,
28(Suppl 1):20–24.
35. Folch J, LEES M, SLOANE STANLEY GH: A simple method for the isolation
and purification of total lipides from animal tissues. J Biol Chem 1957,
226:497–509.
36. Merino DM, Johnston H, Clarke S, Roke K, Nielsen D, Badawi A, et al:
Polymorphisms in FADS1 and FADS2 alter desaturase activity in young
Caucasian and Asian adults. Mol Genet Metab 2011, 103:171–178.
37. Monteiro J, Li FJ, Maclennan M, Rabalski A, Moghadasian MH, Nakamura MT,
et al: Menhaden oil, but not safflower or soybean oil, aids in restoring
the polyunsaturated fatty acid profile in the novel delta-6-desaturase
null mouse. Lipids Health Dis 2012, 11:60.
38. Huang YC, Luedecke LO, Shultz TD: Effect of Cheddar Cheese
Consumption on Plasma Conjugated Linoleic-Acid Concentrations in
Men. Nutr Res 1994, 14:373–386.
39. Zlatanos SN, Laskaridis K, Sagredos A: Conjugated linoleic acid content of
human plasma. Lipids Health Dis 2008, 7:34.
40. Herbel BK, McGuire MK, McGuire MA, Shultz TD: Safflower oil consumption
does not increase plasma conjugated linoleic acid concentrations in
humans. Am J Clin Nutr 1998, 67:332–337.
41. Iversen SA, Cawood P, Dormandy TL: A Method for the Measurement of A
Diene-Conjugated Derivative of Linoleic-Acid, 18-2(9,11), in Serum
Phospholipid, and Possible Origins. Ann Clin Biochem 1985, 22:137–140.
42. Nikpartow N, Danyliw AD, Whiting SJ, Lim HJ, Vatanparast H: Beverage
consumption patterns of Canadian adults aged 19 to 65 years.
Public Health Nutr 2012, 15:2175–2184.
43. Garriguet D: Canadians’ eating habits. Health Rep 2007, 18:17–32.
44. Mauvoisin D, Mounier C: Hormonal and nutritional regulation of SCD1
gene expression. Biochimie 2011, 93:78–86.
45. Josse AR, Garcia-Bailo B, Fischer K, El-Sohemy A: Novel effects of hormonal
contraceptive use on the plasma proteome. PLoS One 2012, 7:e45162.
46. Baylin A, Kim MK, Donovan-Palmer A, Siles X, Dougherty L, Tocco P, et al:
Fasting whole blood as a biomarker of essential fatty acid intake in
epidemiologic studies: comparison with adipose tissue and plasma.
Am J Epidemiol 2005, 162:373–381.
47. Dilzer A, Park Y: Implication of conjugated linoleic acid (CLA) in human
health. Crit Rev Food Sci Nutr 2012, 52:488–513.
doi:10.1186/1743-7075-10-50
Cite this article as: Abdelmagid et al.: Plasma concentration of
cis9trans11 CLA in males and females is influenced by SCD1 genetic
variations and hormonal contraceptives: a cross-sectional study.
Nutrition & Metabolism 2013 10:50.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
